Hongzhu Li Selected Research

Hongzhu Li Research Topics

Disease

8	Ischemia 01/2019 - 12/2011
7	Hypoxia (Hypoxemia) 01/2016 - 02/2012
3	Inflammation (Inflammations) 10/2022 - 01/2018
3	Atherosclerosis 01/2022 - 06/2013
3	Diabetic Cardiomyopathies 01/2021 - 01/2015
3	Fibrosis (Cirrhosis) 01/2020 - 08/2019
3	Infarction (Infarctions) 08/2019 - 01/2016
2	Memory Disorders (Memory Loss) 01/2022 - 01/2021
2	Myocardial Ischemia (Ischemic Heart Diseases) 08/2019 - 02/2009
2	Hypertrophy 07/2016 - 01/2014
2	Cardiomegaly (Heart Hypertrophy) 07/2016 - 01/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2014 - 01/2012
2	Reperfusion Injury 02/2009 - 11/2007
1	Aortic Aneurysm (Aneurysm, Aortic) 10/2022
1	Diabetic Angiopathies (Diabetic Angiopathy) 07/2022
1	Hyperglycemia 01/2022
1	Neuroinflammatory Diseases 01/2021
1	Deglutition Disorders (Dysphagia) 11/2020
1	Stroke (Strokes) 11/2020
1	Pulmonary Hypertension 08/2019
1	Myocardial Reperfusion Injury 08/2019
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2018
1	Osteosarcoma (Osteogenic Sarcoma) 06/2017
1	Hypercholesterolemia 03/2017
1	Diabetes Mellitus 01/2015
1	Myocardial Infarction 01/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2014
1	Hyperhomocysteinemia 06/2013
1	Neointima 03/2012
1	Heart Injuries 02/2012

Drug/Important Bio-Agent (IBA)

4	sodium bisulfide (NaHS)IBA 10/2022 - 03/2012
4	SpermineIBA 01/2021 - 01/2016
4	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2019 - 06/2013
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2013
4	PolyaminesIBA 01/2014 - 11/2007
3	CalciumIBA 01/2020 - 08/2019
3	Calcium-Sensing ReceptorsIBA 08/2019 - 12/2011
2	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 08/2019
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022 - 08/2019
2	LyasesIBA 01/2022 - 03/2017
2	CystathionineIBA 01/2022 - 03/2017
2	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 01/2022 - 06/2017
2	Estrogens (Estrogen)FDA Link 03/2017 - 01/2012
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 07/2016 - 01/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 01/2015
2	Messenger RNA (mRNA)IBA 01/2015 - 07/2013
1	ElastinIBA 10/2022
1	Matrix Metalloproteinases (MMPs)IBA 10/2022
1	Angiotensin IIIBA 10/2022
1	EnzymesIBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Neuroprotective AgentsIBA 01/2021
1	Presenilin-1IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 08/2019
1	UbiquitinIBA 08/2019
1	CollagenIBA 08/2019
1	N(1)- (4- chlorobenzoyl)- N(2)- (1- (1- naphthyl)ethyl)- 1,2- diaminocyclohexaneIBA 08/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2019
1	baicalinIBA 01/2018
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2017
1	Galactose (Galactopyranose)FDA LinkGeneric 10/2016
1	Mitochondrial Permeability Transition PoreIBA 01/2016
1	CreatinineIBA 01/2016
1	Troponin IIBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	p38 Mitogen-Activated Protein KinasesIBA 10/2015
1	Mitogen-Activated Protein Kinase 3IBA 10/2015
1	JNK Mitogen-Activated Protein KinasesIBA 10/2015
1	Oxygen (Dioxygen)IBA 01/2015
1	Caspase 3 (Caspase-3)IBA 01/2015
1	Caspase 9IBA 01/2015
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2014
1	Atrial Natriuretic Factor (ANF)IBA 01/2014
1	Ezetimibe (Zetia)FDA Link 06/2013
1	LDL CholesterolIBA 06/2013
1	Acetylcysteine (Siran)FDA LinkGeneric 06/2013
1	CholesterolIBA 06/2013
1	ApolipoproteinsIBA 06/2013
1	Adenosine Triphosphate (ATP)IBA 02/2012
1	Inositol (Myoinositol)IBA 02/2012
1	triphosphoric acid (triphosphate)IBA 02/2012
1	Type C PhospholipasesIBA 02/2012

Therapy/Procedure

4	Ischemic Postconditioning 01/2019 - 04/2014
2	Electroacupuncture 01/2021 - 11/2020
2	Therapeutics 01/2021 - 01/2016
1	PC protocol 10/2016
1	Intravenous Injections 07/2016
1	Ligation 03/2012